Komal Rizwan

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Microbial Community

Respiratory Syndrome Coronavirus

Oxide Nanoparticles

Top Venues

Molecules (Basel, Switzerland)

Critical reviews in food science and nutrition

Environmental science and pollution research international

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Fatema R Saber, Paulo E S Munekata, Komal Rizwan, Heba A S El-Nashar, Nouran M Fahmy, Shaza H Aly, Mohamed El-Shazly, Abdelhakim Bouyahya, José Manuel Lorenzo Rodriguez
Family Myrtaceae: The treasure hidden in the complex/diverse composition. Critical reviews in food science and nutrition (2023)
Muhammad Salman Javed, Muhammad Zubair, Komal Rizwan, Muhammad Jamil
In Vitro Anti-Microbial Activity and Anti-Cancer Potential of Novel Synthesized Carbamothioyl-Furan-2-Carboxamide Derivatives. Molecules (Basel, Switzerland) 28 (12) (2023)
Muhammad Salman Javed, Muhammad Zubair, Komal Rizwan, Muhammad Jamil
In Vitro Anti-Microbial Activity and Anti-Cancer Potential of Novel Synthesized Carbamothioyl-Furan-2-Carboxamide Derivatives. Molecules (Basel, Switzerland) 28 (12) (2023)
Muhammad Salman Javed, Muhammad Zubair, Komal Rizwan, Muhammad Jamil
In Vitro Anti-Microbial Activity and Anti-Cancer Potential of Novel Synthesized Carbamothioyl-Furan-2-Carboxamide Derivatives. Molecules (Basel, Switzerland) 28 (12) (2023)
Komal Rizwan, Muhammad Bilal
Developments in advanced oxidation processes for removal of microplastics from aqueous matrices. Environmental science and pollution research international 29 (58) (2022)
Muhammad Bilal, Hira Munir, Muhammad Imran Khan, Mohsin Khurshid, Tahir Rasheed, Komal Rizwan, Marcelo Franco, Hafiz M N Iqbal
Gums-based engineered bio-nanostructures for greening the 21st-century biotechnological settings. Critical reviews in food science and nutrition (2021)
Komal Rizwan, Tahir Rasheed, Shakeel Ahmad Khan, Muhammad Bilal, Tahir Mahmood
Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2). Human vaccines & immunotherapeutics 16 (12) (2020)